This document is an excerpt from the EUR-Lex website
Document 62015TB0235(01)
Case T-235/15 R: Order of the President of the General Court of 23 May 2016 — Pari Pharma v EMA (Application for interim measures — Access to documents — Regulation (EC) No 1049/2001 — Documents held by the EMA concerning information submitted by an undertaking as part of its application for authorisation to place a medicinal product on the market — Order granting suspension of operation of the decision to grant a third party access to the documents — Application for cancellation — No change in circumstances — Article 159 of the Rules of Procedure of the General Court)
Case T-235/15 R: Order of the President of the General Court of 23 May 2016 — Pari Pharma v EMA (Application for interim measures — Access to documents — Regulation (EC) No 1049/2001 — Documents held by the EMA concerning information submitted by an undertaking as part of its application for authorisation to place a medicinal product on the market — Order granting suspension of operation of the decision to grant a third party access to the documents — Application for cancellation — No change in circumstances — Article 159 of the Rules of Procedure of the General Court)
Case T-235/15 R: Order of the President of the General Court of 23 May 2016 — Pari Pharma v EMA (Application for interim measures — Access to documents — Regulation (EC) No 1049/2001 — Documents held by the EMA concerning information submitted by an undertaking as part of its application for authorisation to place a medicinal product on the market — Order granting suspension of operation of the decision to grant a third party access to the documents — Application for cancellation — No change in circumstances — Article 159 of the Rules of Procedure of the General Court)
IO C 260, 18.7.2016, p. 39–40
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
- Date of document:
- 23/05/2016
- Date lodged:
- 21/04/2016
- Author:
- Cúirt Ghinearálta
- Form:
- Faisnéis bhreithiúnach
- Authentic language:
- Béarla
- Type of procedure:
- Iarratas ar bhearta eatramhacha - gan bhunús, Caingean le haghaidh neamhniú
- Link
- Select all documents mentioning this document
- Case affecting:
-
- Related EU case-law document 62015TO0235(04)
- Instruments cited in case law:
- Link
- EUROVOC descriptor:
|
18.7.2016 |
EN |
Official Journal of the European Union |
C 260/39 |
Order of the President of the General Court of 23 May 2016 — Pari Pharma v EMA
(Case T-235/15 R)
((Application for interim measures - Access to documents - Regulation (EC) No 1049/2001 - Documents held by the EMA concerning information submitted by an undertaking as part of its application for authorisation to place a medicinal product on the market - Order granting suspension of operation of the decision to grant a third party access to the documents - Application for cancellation - No change in circumstances - Article 159 of the Rules of Procedure of the General Court))
(2016/C 260/49)
Language of the case: English
Parties
Applicant: Pari Pharma GmbH (Starnberg, Germany) (represented by: M. Epping and W. Rehmann, lawyers)
Defendant: European Medicines Agency (represented by: T. Jabłoński, N. Rampal Olmedo, A. Spina, A. Rusanov and S. Marino, acting as Agents)
Intervener in support of the defendant: Novartis Europharm Ltd (Camberley, United Kingdom) (represented by: C. Schoonderbeek, lawyer)
Re:
Application based on Article 159 of the Rules of Procedure of the General Court seeking the cancellation of the order of 1 September 2015 in Pari Pharma v EMA (T-235/15 R, EU:T:2015:587), by which it granted the suspension of operation of Decision EMA/271043/2015 of the EMA of 24 April 2015, granting to a third party, pursuant to Regulation (EC) No 1049/2001 of the European Parliament and of the Council of 30 May 2001 regarding public access to European Parliament, Council and Commission documents (OJ 2001 L 145, p. 43), access to certain documents containing information submitted in the context of an application for marketing authorisation for the medicinal product Vantobra.
Operative part of the order
|
1. |
The request seeking the cancellation of the order of 1 September 2015 in Pari Pharma v EMA (T-235/15 R, EU:T:2015:587) is rejected. |
|
2. |
The costs are reserved. |
